| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.036 | 0.5 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.036 | 0.5 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.5 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.051 | 0.5 |